Onemednet (ONMD)Director bought ~$500K
Thomas Kosasa, Director at Onemednet, bought ~$500K of Onemednet shares.
- ~$500K
- Approx. value · 595K sh @ $0.84
- 16.4M
- Holds after · shares reported
- Traded
- Feb 6, 2026
- Filed
- Apr 24, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 22, 2025InsiderCEO sold ~$145K of ONMD shares in the open market
- Nov 18, 2025InsiderCEO sold ~$74K of ONMD shares in the open market
- Feb 6, 2026 · this disclosureInsiderDirector purchased ~$500K of ONMD shares in the open market
What came next
- Apr 1, 2026Insider · 13 days before an 8-KDirector purchased ~$750K of ONMD shares in the open market
- Apr 14, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On April 14, 2026, OneMedNet Corporation (the “Company”) received notice (the “Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company, based on the closing bid price of the Company’s common stock for the last 30 consecutive business days, is not in compliance with the $1.00 minimum bid price requirement for continued…”
- Apr 23, 2026InsiderDirector purchased ~$250K of ONMD shares in the open market
- May 18, 2026InsiderDirector purchased ~$250K of ONMD shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Onemednet
For Onemednet, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ONMD page.
Other recent filings by Thomas Kosasa, Director
- SEC Form 4 at Onemednet (ONMD)Aug 7, 2026
- SEC Form 4 at Onemednet (ONMD)Jun 15, 2026
- SEC Form 4 at Onemednet (ONMD)May 20, 2026
- SEC Form 4 at Onemednet (ONMD)Apr 24, 2026
- SEC Form 4 at Onemednet (ONMD)Nov 27, 2025
The full history of Thomas Kosasa, Director is on the profile page.
How this filing works
Other disclosures at Onemednet
- SEC Form 4Oct 10, 2026
- SEC Form 4Oct 10, 2026
- SEC Form 4Oct 10, 2026
- SEC Form 4Oct 10, 2026
- SEC Form 4Oct 10, 2026
- SEC Form 4Sep 15, 2026
Everything OQRO holds on this company is on its ONMD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
